| CSSAX | WCMNX | CSSAX / WCMNX | |
| Total Expense Ratio | 1.14 | 1.24 | 92% |
| Annual Report Gross Expense Ratio | 1.14 | 2.04 | 56% |
| Fund Existence | 8 years | 6 years | - |
| Gain YTD | 7.687 | 6.304 | 122% |
| Front Load | 5% | N/A | - |
| Min. Initial Investment | 1000 | 1000 | 100% |
| Min. Initial Investment IRA | N/A | N/A | - |
| Net Assets | 236M | 41.9M | 563% |
| Annual Yield % from dividends | 0.00 | 0.00 | - |
| Returns for 1 year | -6.94 | -3.16 | 220% |
| Returns for 3 years | 19.17 | 22.08 | 87% |
| Returns for 5 years | -6.66 | 3.45 | -193% |
| Returns for 10 years | N/A | N/A | - |
| 1 Day | |||
|---|---|---|---|
| MFs / NAME | Price $ | Chg $ | Chg % |
| THISX | 91.23 | -0.47 | -0.51% |
| T. Rowe Price Health Sciences I | |||
| PVMIX | 16.20 | -0.19 | -1.16% |
| Principal MidCap Value I Inst | |||
| MOPIX | 28.16 | -0.64 | -2.22% |
| NYLI WMC Small Companies Class I | |||
| LPEFX | 6.28 | -0.16 | -2.48% |
| ALPS Global Opportunity Inv | |||
| PARNX | 63.15 | -1.77 | -2.73% |
| Parnassus Mid Cap Growth Investor | |||